Peter Arduini

Peter Arduini has led GE HealthCare as President and CEO since its spin-off from General Electric in January 2023. The separation created an independent, focused medical technology company with approximately $20 billion in annual revenue and an installed base of over 4 million devices in hospitals and healthcare facilities across more than 160 countries. GE HealthCare operates in four segments: Imaging (MRI scanners, CT scanners, X-ray, PET/CT, and molecular imaging — the largest segment, where GE HealthCare is one of three global leaders alongside Siemens Healthineers and Philips), Ultrasound (a global leader in ultrasound systems across radiology, cardiology, and women's health), Patient Care Solutions (patient monitoring, anesthesia delivery, respiratory care), and Pharmaceutical Diagnostics (contrast agents for medical imaging — GE HealthCare is the global leader). Arduini's strategic priorities include accelerating AI integration across the product portfolio (AI algorithms that help radiologists detect and diagnose conditions faster), growing the service and digital revenue streams (recurring revenue from maintenance, software subscriptions, and data analytics), expanding in high-growth markets (China, India, Southeast Asia), and improving margins now that the company operates independently. Key stock drivers include hospital capital spending on medical equipment, AI feature monetization, imaging system replacement cycles, pharmaceutical diagnostics volumes, geographic revenue mix (particularly China policy risk), competitive dynamics against Siemens Healthineers and Philips, and margin expansion trajectory as an independent company.